Additionally, IL-19 has been shown to modulate α-SMA expression via CCL2 and TGF-β signaling pathways in models of diabetes-induced kidney damage, contributing to fibrosis development (Ni et al., 2018). This evidence concerns the gene CCL2 and diabetes mellitus.